New Ray Medicine International Holdings Limited (New Ray Medicine) submitted the latest monthly report on securities changes to the Hong Kong Exchanges and Clearing Limited on September 2, 2024, reporting the company's shareholding changes as of August 31, 2024. The report shows that the company's statutory/registered share capital and the number of issued shares remained unchanged during the reporting period, with a total of 3,000,000,000 shares and 1,671,846,657 shares, respectively, with a par value of 0.05 Hong Kong dollars per share. In addition, as of the end of this month, the number of share options under the share option plan adopted by the company on October 25, 2013, is 128,200,000 shares, with no changes during this month. The company confirms that all securities issued or treasury shares sold or transferred have been authorized by the board of directors and comply with relevant listing rules and legal requirements. The report was submitted by the company secretary, Wu Risheng.

New Ray Medicine International Holdings Limited (New Ray Medicine) submitted the latest monthly report on securities changes to the Hong Kong Exchanges and Clearing Limited on September 2, 2024, reporting the company's shareholding changes as of August 31, 2024. The report shows that the company's statutory/registered share capital and the number of issued shares remained unchanged during the reporting period, with a total of 3,000,000,000 shares and 1,671,846,657 shares, respectively, with a par value of 0.05 Hong Kong dollars per share. In addition, as of the end of this month, the number of share options under the share option plan adopted by the company on October 25, 2013, is 128,200,000 shares, with no changes during this month. The company confirms that all securities issued or treasury shares sold or transferred have been authorized by the board of directors and comply with relevant listing rules and legal requirements. The report was submitted by the company secretary, Wu Risheng.